IntrinsicIntrinsic
← Scroll for more →

Financial Statements — ECG

Balance Sheet

(in billions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025Q1 2025Q3 2024
Cash & Equivalents0.180.290.150.080.070.00
Accounts Receivable0.920.780.740.680.59--
Inventory0.060.050.050.050.050.05
Total Current Assets1.481.421.221.090.970.89
Property, Plant & Equipment0.190.170.150.150.150.13
Goodwill0.210.140.140.140.140.14
Intangible Assets0.060.000.000.000.000.00
Total Non-current Assets0.580.430.410.390.380.39
Total Assets2.061.851.621.481.361.28
Accounts Payable0.280.260.210.200.180.16
Total Current Liabilities0.930.800.690.610.550.56
Long-term Debt0.270.280.290.290.290.21
Total Non-current Liabilities0.350.360.360.350.350.27
Total Liabilities1.281.161.050.970.900.83
Retained Earnings0.630.540.430.370.320.32
Total Stockholder Equity0.770.690.570.510.460.45
← Scroll for more columns →

Income Statement

(in billions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total Revenue1.231.041.010.990.920.830.760.76
Cost of Revenue1.050.910.890.860.800.730.670.67
Gross Profit0.180.130.120.120.120.090.090.09
Selling, General & Admin0.070.050.050.050.050.040.040.02
Total Operating Expenses0.070.050.050.050.050.040.040.04
Operating Income0.110.080.070.070.070.050.050.05
Pretax Income0.110.080.070.070.070.050.040.05
Tax Provision0.030.020.020.020.020.010.010.01
Net Income0.080.060.060.060.050.040.030.04
Basic EPS1.641.141.071.121.040.720.670.82
Diluted EPS1.641.141.091.111.030.720.670.82
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Operating Cash Flow53.14143.6848.2176.1725.347.1380.6982.68
Capital Expenditures20.1315.4724.7210.5013.0818.5413.7734.51
Free Cash Flow*33.01128.2123.4965.6712.26(11.41)66.9248.18
Investing Cash Flow(165.87)(14.30)(23.12)(7.96)(10.86)(14.82)(11.57)(25.49)
Financing Cash Flow(3.95)(6.52)(3.75)(3.75)(3.75)(4.34)16.34(58.21)
← Scroll for more columns →

* Derived from reported values